Josephine Y. Tsang
102 Pokfulam Road
Hong Kong, China
Hong Kong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab, lenvatinib, carboplatin and pemetrexed in patients with metastatic non-small cell lung cancer harbouring targetable genomic alterations who progressed on standard tyrosine kinase inhibitors.
Journal: Investigational new drugs
Published: August 25, 2025
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers.
Journal: Advances in therapy
Published: August 24, 2021
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.
Journal: Postgraduate medical journal
Published: April 20, 2021
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.
Journal: Advances in therapy
Published: March 28, 2021
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib.
Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib.
Journal: Expert review of gastroenterology & hepatology
Published: March 05, 2021
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: December 26, 2020
Robotic endovascular surgery.
Journal: Asian cardiovascular & thoracic annals
Published: March 04, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026